WeVote
Log In

Bill

Bill

AJR 104

Relating to: proclaiming November 2025 to be Pancreatic Cancer Awareness Month.

2025-2026 Regular Session Introduced by Margaret Arney and 24 co-sponsors

AJR 104 designates November 2025 as Pancreatic Cancer Awareness Month, a symbolic joint resolution to raise awareness and education with no new laws or state funding.

Failed to adopt pursuant to Senate Joint Resolution 1
0
WeVote Research Nonpartisan
Bill Summary · AJR 104

AJR 104 — Pancreatic Cancer Awareness Month (November 2025)

Purpose and Intent

  • AJR 104 is a joint resolution that would formally proclaim November 2025 as Pancreatic Cancer Awareness Month within the state. As a ceremonial/recognition measure, it states the Legislature’s intent to raise awareness about pancreatic cancer and recognize efforts by patients, families, researchers, and advocacy groups.

Key Provisions

  • Proclamation: Designates November 2025 as Pancreatic Cancer Awareness Month.
  • Observance: Encourages public officials, health organizations, schools, and citizens to observe and participate in activities that promote awareness and education about pancreatic cancer.
  • Nature of Action: Being a joint resolution, the measure expresses the views and stance of the Legislature rather than creating new statutes or authorizing state spending.

Note: The specific text of additional actions (e.g., required gubernatorial proclamation or mandated programs) is not provided in the summary materials. The bill’s effect is primarily symbolic and educational.

Sponsors and Legislative History

  • Primary Sponsors: Kirsch, McCarville, Joers, Johnson, Bare, Sinicki, Spaude, Mursau, Stubbs, Stroud, Emerson, Ortiz-Velez, Arney, Mayadev, Clancy, Roe, J. Jacobson, Palmeri, Miresse, Novak, DeSmidt, Madison, Melotik, Tenorio, Fitzgerald.
  • Introduced: October 9, 2025 by a broad group of Representatives; cosponsored by a group of Senators.
  • Early Action: Read and referred to Committee on Rules on October 9, 2025.
  • Status Update: On October 10, 2025, Representative Subeck was added as a coauthor.

Procedural and Timeline Aspects

  • Type: Joint resolution (AJR), not a bill creating new law or allocating funds.
  • Path: Introduction, referral to Rules; subsequent advancement would typically proceed through committee and floor consideration as with other non-fiscal joint resolutions.
  • Effective Date: If enacted, the designation would apply to November 2025.

Potential Impact and Stakeholders

  • Impact: Primarily symbolic—aims to elevate public awareness, education, and recognition of pancreatic cancer issues within the state.
  • Stakeholders: Pancreatic cancer patients and families, healthcare professionals, researchers, advocacy organizations, educational institutions, and the general public.
  • Budget/Fiscal: No explicit funding or statutory changes are indicated; no direct fiscal impact anticipated beyond potential costs associated with any awareness activities if organized by state agencies.

This summary provides the essential details to understand what AJR 104 seeks to achieve, who is sponsoring it, and the practical implications of its passage.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.